Last update : 05/03/2021 | Version : 1 | ID : 73765
General | |
Identification | |
Detailed name | Observational, prospective, multicentre cohort of patients followed up after hospitalisation to evaluate respiratory sequelae subsequent to SARS-CoV-2 (COVID-19) infection |
Sign or acronym | SISCOVID |
General Aspects | |
Medical area |
Pneumology |
Study in connection with Covid-19 |
Yes |
Scientific investigator(s) (Contact) | |
Name of the director | CALCAIANU |
Surname | George |
Address | Groupement Hospitalier de la Région de Mulhouse et Sud-Alsace / GHRMSA |
george-daniel.calcaianu@ghrmsa.fr | |
Collaborations | |
Details | 13 associated centers (CHR Orléans, CH Colmar, CHD La Roche Sur Yon, CH de la Côte Basque, CH Le Raincy Montfermeil, CH Douai, CHR Metz-Thionville, CH du Mans, CH Dunkerque, CH Soissons, CH Libourne, CH Annecy, CH Chambéry) |
Funding | |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | GHRMSA health institution |
Organisation status |
Public |
Additional contact | |
marie.diesel@ghrmsa.fr | |
Main features | |
Type of database | |
Type of database |
Others |
Specify | eCRF |
Database recruitment is carried out as part of an interventional study |
No |
Database objective | |
Main objective |
Evaluate the respiratory sequelae after SARS-CoV-2 infection in patients hospitalised for severe COVID-19 pneumonia requiring O2, with subsequent outpatient follow-up (6 months) by:
- Low-dose chest CT scan (LD-chest CT), - Static lung function tests (LFT), - Arterial blood gases in ambient air at rest (AA BG) and/or with oxygen (O2 BG), - 6-minute walking test in ambient air (6WT AA) and/or with oxygen (6WT O2) |
Inclusion criteria |
Patient having received verbal information and not objecting to the study
Age >= 18 years inclusive Patient hospitalised for severe COVID-19 pneumonia requiring O2 Patient having contracted SARS-CoV-2 infection proven by RT-PCR and/or retrospective serology and/or COVID-19 syndrome with chest CT scan consistent with infection (over the period from 1 March 2020 to 30 June 2020) |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
Population covered |
Sick population |
Pathology | J12 - Viral pneumonia, not elsewhere classified |
Gender |
Male Woman |
Geography area |
National |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2020 |
Size of the database | |
Size of the database (number of individuals) |
< 500 individuals |
Data | |
Database activity |
Current data collection |
Type of data collected |
Clinical data Biological data |
Clinical data (detail) |
Direct physical measures Medical registration |
Presence of a biobank |
No |
Procedures | |
Followed pathology | |
Promotion and access | |
Promotion | |
Access |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05